Capricor Therapeutics DSO Ratio 2011-2026 | CAPR

Annual DSO Ratio Capricor Therapeutics

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	-	-	-	31.9	44.7	47.2	20.4	14	27.5	0.136	-	-

All numbers in USD currency

Maximum	Minimum	Average
47.2	0.136	26.6

Issuer	DSO Ratio	Price	% 24h	Market Cap	Country
Assembly Biosciences ASMB	25.1	$ 28.46	3.45 %	$ 319 M	USA
Ascendis Pharma A/S ASND	132	$ 221.88	-0.87 %	$ 5 B	Danmark
Axsome Therapeutics AXSM	105	$ 156.92	-1.23 %	$ 7.81 B	USA
Kamada Ltd. KMDA	103	$ 8.5	-1.39 %	$ 260 M	Israel
I-Mab IMAB	271	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	84.7	-	-	$ 40.3 B	USA
Benitec Biopharma BNTC	141	$ 10.98	-4.52 %	$ 452 M	USA
Compugen Ltd. CGEN	60.8	$ 2.09	-0.95 %	$ 195 M	Israel
Midatech Pharma plc MTP	204	-	-18.52 %	$ 27.3 M	Britain
EyeGate Pharmaceuticals, Inc. EYEG	2.75 K	-	-1.52 %	$ 24.7 M	USA
Aeterna Zentaris AEZS	146	-	5.93 %	$ 314 M	Canada
Applied Genetic Technologies Corporation AGTC	0.114	-	-	$ 26.5 M	USA
Acorda Therapeutics ACOR	48.3	-	-24.86 %	$ 820 K	USA
Acasti Pharma ACST	1.97	-	4.01 %	$ 150 M	Canada
Adverum Biotechnologies ADVM	222	-	-	$ 86.2 M	USA
Advaxis ADXS	88.1	-	-9.65 %	$ 45.9 M	USA
AbCellera Biologics ABCL	173	$ 3.4	-3.68 %	$ 1.02 B	Canada
BioMarin Pharmaceutical BMRN	88.9	$ 54.13	-1.64 %	$ 10.4 B	USA
Curis CRIS	103	$ 0.77	1.89 %	$ 4.86 M	USA
AgeX Therapeutics AGE	78.4	-	-10.17 %	$ 12.2 K	USA
Coherus BioSciences CHRS	559	$ 1.52	-5.59 %	$ 178 M	USA
Aeglea BioTherapeutics AGLE	216	-	-	$ 1.01 B	USA
CureVac N.V. CVAC	13.6	-	-	$ 867 M	Germany
Cellectis S.A. CLLS	94.5	$ 3.34	-4.02 %	$ 116 M	France
Arbutus Biopharma Corporation ABUS	31.5	$ 4.24	-2.97 %	$ 704 M	Canada
Albireo Pharma ALBO	14.7	-	-0.23 %	$ 916 M	USA
AIkido Pharma AIKI	17.9	-	1.93 %	$ 17.4 M	USA
Cardiff Oncology CRDF	294	$ 1.8	-1.1 %	$ 120 M	USA
Iterum Therapeutics ITRM	740	$ 0.16	-5.45 %	$ 3.15 M	Irlanda
Brickell Biotech BBI	254	-	-5.38 %	$ 6.06 M	USA